CJC-1295 WITHOUT DAC + IPAS

CJC-1295 Without DAC + Ipamorelin (IPAS) – Advanced Growth Hormone Research Blend

CJC-1295 Without DAC + Ipamorelin (IPAS) is a premium research peptide combination formulated for advanced studies in growth hormone release pathways, metabolic performance, and recovery-related biochemical processes. This synergistic blend is widely researched for its ability to stimulate natural growth hormone signaling without prolonged activity, making it ideal for short-acting and controlled research applications.

CJC-1295 Without DAC works as a growth hormone–releasing hormone (GHRH) analog, while Ipamorelin functions as a growth hormone secretagogue (GHS). Together, they create a powerful research pairing designed to support investigations into muscle development pathways, fat metabolism, sleep-related hormone cycles, and overall metabolic efficiency.

Key Features of CJC-1295 Without DAC + Ipamorelin:

• High-purity dual-peptide research formulation

• Studied for stimulating growth hormone release pathways

• Short-acting profile for precise research control

• Supports research into muscle, recovery, and metabolic mechanisms

• Manufactured under strict quality and purity standards

• Research-grade compound for laboratory and experimental use

Why Choose CJC-1295 Without DAC + Ipamorelin?

This peptide combination stands out for its synergistic interaction on growth hormone pathways without extended half-life activity. Its balanced formulation allows researchers to examine pulsatile hormone release patterns and metabolic performance with greater precision and flexibility.

Each batch is independently tested to ensure purity, consistency, and stability. Carefully packaged to preserve integrity, this blend delivers reliable performance for scientific research and controlled laboratory environments.

Product Specifications:

• Product Name: CJC-1295 Without DAC + Ipamorelin (IPAS)

• Purity: ≥ 99%

• Form: Lyophilized powder

• Storage: Store refrigerated for long-term stability

• Intended Use: For research and laboratory purposes only

Ideal For Research In:

• Growth hormone release pathways

• Muscle and recovery mechanisms

• Fat metabolism and body composition

• Sleep-related hormonal cycles

• Metabolic performance research

The CJC-1295 Without DAC + Ipamorelin is a powerful
research peptide combination designed to stimulate growth hormone (GH) release through multiple mechanisms of action. This blend combines CJC-1295 No DAC , a GHRH analog that supports natural growth hormone pulsation, with Ipamorelin , a GHRP that acts on the ghrelin receptor (GHSR) to create a synergistic effect. This peptide blend is manufactured to high laboratory standards and verified via High-Performance Liquid Chromatography (HPLC) to ensure ≥ 99% purity. This combination is intended only for controlled in vitro endocrinological and biochemical research.

Contents of the blend

• CJC-1295 without DAC – 5 mg: Studied for its role in the natural pulsatile release of growth hormone via the GHRH receptor.
• Ipamorelin – 5 mg: Studied for its selective stimulation of the ghrelin receptor without affecting cortisol or prolactin.

Important specifications

Application & Use (for research purposes only)

• For in vitro research purposes only .
• Not suitable for human or animal consumption or medical use.
• To be used for endocrine research on growth hormone regulation and ghrelin activation .